SPDR Health Care E.T.F.

XLV-N

NYSEARCA:XLV

100.41
0.66 (0.66%)

Analysis and Opinions about XLV-N

Signal
Opinion
Expert
TOP PICK
TOP PICK
February 17, 2017

Just the big names in US healthcare. We have seen the bottom in here. It is one of the strongest sectors out there right now. We saw some rotation last week. It is in a secular bull market and we are at the beginning of it. It has a really good valuation. The political football that it has been is going to die down.

Just the big names in US healthcare. We have seen the bottom in here. It is one of the strongest sectors out there right now. We saw some rotation last week. It is in a secular bull market and we are at the beginning of it. It has a really good valuation. The political football that it has been is going to die down.

Hap (Robert) Sneddon FCSI
Chief Portfolio Manager & Founder, Castlemoore Inc.
Price
$73.660
Owned
Yes
COMMENT
COMMENT
October 7, 2016

Good time for a US healthcare ETF? This should be a good area to get into because of an aging population. Demographics are certainly in favour. If he was going to do anything, this would be the one he would go with.

Good time for a US healthcare ETF? This should be a good area to get into because of an aging population. Demographics are certainly in favour. If he was going to do anything, this would be the one he would go with.

David Cockfield
Managing Director, Northland Wealth Management
Price
$71.870
Owned
Unknown
COMMENT
COMMENT
June 30, 2016

Which stocks for RESP and University in 8 years? He would use healthcares such as SPDR Health Care (XLV-N) or SPDR Pharma (XPH-N). These are in a secular bull market. You could also use Van Eck Vectors Biotech (BBH-Q). This gives you a little bit of mix of all 3 sectors. He would suggest 40% and 40% on the first 2 and maybe 20% in the Biotechs.

Which stocks for RESP and University in 8 years? He would use healthcares such as SPDR Health Care (XLV-N) or SPDR Pharma (XPH-N). These are in a secular bull market. You could also use Van Eck Vectors Biotech (BBH-Q). This gives you a little bit of mix of all 3 sectors. He would suggest 40% and 40% on the first 2 and maybe 20% in the Biotechs.

Hap (Robert) Sneddon FCSI
Chief Portfolio Manager & Founder, Castlemoore Inc.
Price
$71.705
Owned
Unknown
DON'T BUY
DON'T BUY
May 5, 2016

Healthcare does better in August and into October. But it ran up since February. We have that political football. Be careful because it is an election year.

Healthcare does better in August and into October. But it ran up since February. We have that political football. Be careful because it is an election year.

Brooke Thackray
Research Analyst, Horizons ETFs (Canada) Inc.
Price
$69.590
Owned
Unknown
TOP PICK
TOP PICK
April 18, 2016

There are very few sectors that are in a bull market on a secular basis. This is one of them. It started in 2014. Was a little bit of a football recently. He started by taking a small position of 2.5%. This is coming into a strong seasonal period.

There are very few sectors that are in a bull market on a secular basis. This is one of them. It started in 2014. Was a little bit of a football recently. He started by taking a small position of 2.5%. This is coming into a strong seasonal period.

Hap (Robert) Sneddon FCSI
Chief Portfolio Manager & Founder, Castlemoore Inc.
Price
$70.670
Owned
Yes
PAST TOP PICK
PAST TOP PICK
December 10, 2015

(A Top Pick June 29/15. Down 3.4%.) Likes healthcare and wouldn’t sell this. Healthcare is one of those areas that is a good position to have in a portfolio.

(A Top Pick June 29/15. Down 3.4%.) Likes healthcare and wouldn’t sell this. Healthcare is one of those areas that is a good position to have in a portfolio.

Richard Croft
President, R.N. Croft Financial Group Inc.
Price
$71.350
Owned
Yes
PAST TOP PICK
PAST TOP PICK
October 15, 2015

(Top Pick Oct 31/14, Up 2.23%) It was way higher two months ago. He got out a month ago. He still likes it long term. He thinks there will be good opportunities to grab this for the long term in the next couple of months.

(Top Pick Oct 31/14, Up 2.23%) It was way higher two months ago. He got out a month ago. He still likes it long term. He thinks there will be good opportunities to grab this for the long term in the next couple of months.

Hap (Robert) Sneddon FCSI
Chief Portfolio Manager & Founder, Castlemoore Inc.
Price
$69.140
Owned
No
PAST TOP PICK
PAST TOP PICK
October 15, 2015

(A Top Pick June 29/15. Down 6.39%.) Healthcare and biotech have been hit pretty hard lately. He really likes this on a longer-term basis. This is an area that continues to be very, very important, and this will continue to do well. If you own, continue to Hold. Still a Buy.

(A Top Pick June 29/15. Down 6.39%.) Healthcare and biotech have been hit pretty hard lately. He really likes this on a longer-term basis. This is an area that continues to be very, very important, and this will continue to do well. If you own, continue to Hold. Still a Buy.

Richard Croft
President, R.N. Croft Financial Group Inc.
Price
$69.140
Owned
Yes
TOP PICK
TOP PICK
June 29, 2015

The healthcare sector should probably be one of your core sectors holdings and you can hold this for the long-term. It is a play on major US healthcare providers. There is going to be continued consolidation in the sector, because margins will be squeezed.

The healthcare sector should probably be one of your core sectors holdings and you can hold this for the long-term. It is a play on major US healthcare providers. There is going to be continued consolidation in the sector, because margins will be squeezed.

Richard Croft
President, R.N. Croft Financial Group Inc.
Price
$74.150
Owned
No
TOP PICK
TOP PICK
June 24, 2015

All 3 picks are in healthcare. There is a huge wave of baby boomers that will be coming through this market and making demands on the healthcare system. This will exhaust itself in probably 15 years. This one has a lot of the big guys in that, such as Pfizer, Johnson & Johnson, Merck, etc.

All 3 picks are in healthcare. There is a huge wave of baby boomers that will be coming through this market and making demands on the healthcare system. This will exhaust itself in probably 15 years. This one has a lot of the big guys in that, such as Pfizer, Johnson & Johnson, Merck, etc.

John Hood
President & Portfolio Manager, J. C Hood Investment.
Price
$75.680
Owned
Yes
TOP PICK
TOP PICK
October 31, 2014

Healthcare. Chart shows a V bottom this month. As a longer-term investor, he would like to hold this for a while. If it came back to the breakout level in the low $60, he would like to buy some more. Healthcare is a generational thing that we are just embarking on.

Healthcare. Chart shows a V bottom this month. As a longer-term investor, he would like to hold this for a while. If it came back to the breakout level in the low $60, he would like to buy some more. Healthcare is a generational thing that we are just embarking on.

Hap (Robert) Sneddon FCSI
Chief Portfolio Manager & Founder, Castlemoore Inc.
Price
$67.270
Owned
Yes
DON'T BUY
DON'T BUY
June 18, 2013

Healthcare. This is strictly US with about 48% pharma. Likes the sector but thinks the ETF has too much pharma.

Healthcare. This is strictly US with about 48% pharma. Likes the sector but thinks the ETF has too much pharma.

Michael Bowman
Portfolio Manager, Wickham Investment Management
Price
$49.060
Owned
No
COMMENT
COMMENT
January 16, 2013

Which ETF would you recommend to play the healthcare sector in the US? SPDR Health Care (XLV-N) generally does a pretty good job. If you don’t want to through the US, there is also BMO EqWt US HthCare Hedged CAD (ZUH-T) on the Canadian market.

Which ETF would you recommend to play the healthcare sector in the US? SPDR Health Care (XLV-N) generally does a pretty good job. If you don’t want to through the US, there is also BMO EqWt US HthCare Hedged CAD (ZUH-T) on the Canadian market.

Terry Shaunessy
President & portfolio manager, Shaunessy Investment Counsel
Price
$41.670
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
May 9, 2008
(A Top Pick Oct 27/07. Down 11%.) This was basically a defensive play to the end of the year and was up at that time. Still a Buy.
(A Top Pick Oct 27/07. Down 11%.) This was basically a defensive play to the end of the year and was up at that time. Still a Buy.
Brooke Thackray
Research Analyst, Horizons ETFs (Canada) Inc.
Price
$31.470
Owned
No
TOP PICK
TOP PICK
October 26, 2007
(SPDR Health Care E.T.F) Health care does well in the summer time, people like to take from aggressive positions and put money in defensive positions during holidays. Should sell at end of the year, before J.P Morgan health care conference takes place.
(SPDR Health Care E.T.F) Health care does well in the summer time, people like to take from aggressive positions and put money in defensive positions during holidays. Should sell at end of the year, before J.P Morgan health care conference takes place.
Brooke Thackray
Research Analyst, Horizons ETFs (Canada) Inc.
Price
$35.680
Owned
Yes
Showing 16 to 30 of 31 entries